Table 1 Baseline characteristics of rheumatoid arthritis patients treated with adalimumab a
From: Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
Characteristics | Data |
|---|---|
Gender (% women) | 92.8 |
Mean age (±SD), yr | 56.6 ± 13.6 |
Mean disease duration (±SD), yr | 13.8 ± 11.2 |
Mean RF + and/or ACPA + (%) | 78.6 |
Mean concomitant methotrexate (%) | 64.3 |
Mean concomitant prednisone (%) | 64.3 |
Mean previous DMARDs, number (range) | 3.07 (1 to 5) |
Mean ESR, mm/h (±SD) | 40.1 ± 23.6 |
Mean CRP, mg/L (±SD) | 15.6 ± 17.8 |
Mean DAS28-ESR, IU (±SD) | 5.05 ± 0.95 |